Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.
Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group. Lewis EJ, et al. Among authors: atkins rc. Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Am J Kidney Dis. 2011. PMID: 21872376 Clinical Trial.
Pyridorin in type 2 diabetic nephropathy.
Lewis EJ, Greene T, Spitalewiz S, Blumenthal S, Berl T, Hunsicker LG, Pohl MA, Rohde RD, Raz I, Yerushalmy Y, Yagil Y, Herskovits T, Atkins RC, Reutens AT, Packham DK, Lewis JB; Collaborative Study Group. Lewis EJ, et al. Among authors: atkins rc. J Am Soc Nephrol. 2012 Jan;23(1):131-6. doi: 10.1681/ASN.2011030272. Epub 2011 Oct 27. J Am Soc Nephrol. 2012. PMID: 22034637 Free PMC article. Clinical Trial.
Epidemiology of diabetic nephropathy.
Reutens AT, Atkins RC. Reutens AT, et al. Among authors: atkins rc. Contrib Nephrol. 2011;170:1-7. doi: 10.1159/000324934. Epub 2011 Jun 9. Contrib Nephrol. 2011. PMID: 21659752 Review.
Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.
Packham DK, Wolfe R, Reutens AT, Berl T, Heerspink HL, Rohde R, Ivory S, Lewis J, Raz I, Wiegmann TB, Chan JC, de Zeeuw D, Lewis EJ, Atkins RC; Collaborative Study Group. Packham DK, et al. Among authors: atkins rc. J Am Soc Nephrol. 2012 Jan;23(1):123-30. doi: 10.1681/ASN.2011040378. Epub 2011 Oct 27. J Am Soc Nephrol. 2012. PMID: 22034636 Free PMC article. Clinical Trial.
Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC; Collaborative Study Group. Ivory SE, et al. Among authors: atkins rc. Nephrology (Carlton). 2013 Jul;18(7):516-24. doi: 10.1111/nep.12053. Nephrology (Carlton). 2013. PMID: 23506627 Clinical Trial.
Impact of irbesartan, blood pressure control, and proteinuria on renal outcomes in the Irbesartan Diabetic Nephropathy Trial.
Hunsicker LG, Atkins RC, Lewis JB, Braden G, de Crespigny PJ, DeFerrari G, Drury P, Locatelli F, Wiegmann TB, Lewis EJ; Collaborative Study Group. Hunsicker LG, et al. Among authors: atkins rc. Kidney Int Suppl. 2004 Nov;(92):S99-101. doi: 10.1111/j.1523-1755.2004.09223.x. Kidney Int Suppl. 2004. PMID: 15485429 Free article. Review.
400 results